Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 39

1.

Personalized medicine in cardiovascular diseases.

Lee MS, Flammer AJ, Lerman LO, Lerman A.

Korean Circ J. 2012 Sep;42(9):583-91. doi: 10.4070/kcj.2012.42.9.583. Epub 2012 Sep 27.

2.

The potential application of personalized preventive research.

Song M, Lee HW, Kang D.

Jpn J Clin Oncol. 2014 Nov;44(11):1017-24. doi: 10.1093/jjco/hyu135. Epub 2014 Sep 23. Review.

PMID:
25249379
3.

Clinical practice on the horizon: personalized medicine.

Chadwell K.

Clin Nurse Spec. 2013 Jan-Feb;27(1):36-43. doi: 10.1097/NUR.0b013e318277703c. Review.

PMID:
23222027
4.

Genomic and personalized medicine: foundations and applications.

Ginsburg GS, Willard HF.

Transl Res. 2009 Dec;154(6):277-87. doi: 10.1016/j.trsl.2009.09.005. Epub 2009 Oct 1. Review.

PMID:
19931193
5.

Personalized medicine policy challenges: measuring clinical utility at point of care.

van Rooij T, Wilson DM, Marsh S.

Expert Rev Pharmacoecon Outcomes Res. 2012 Jun;12(3):289-95. doi: 10.1586/erp.12.15. Review.

PMID:
22812553
6.

How to develop cost-conscious guidelines.

Eccles M, Mason J.

Health Technol Assess. 2001;5(16):1-69. Review.

7.

Personalized medicine: progress and promise.

Chan IS, Ginsburg GS.

Annu Rev Genomics Hum Genet. 2011;12:217-44. doi: 10.1146/annurev-genom-082410-101446. Review.

PMID:
21721939
8.

Personalized cardiovascular medicine: concepts and methodological considerations.

Völzke H, Schmidt CO, Baumeister SE, Ittermann T, Fung G, Krafczyk-Korth J, Hoffmann W, Schwab M, Meyer zu Schwabedissen HE, Dörr M, Felix SB, Lieb W, Kroemer HK.

Nat Rev Cardiol. 2013 Jun;10(6):308-16. doi: 10.1038/nrcardio.2013.35. Epub 2013 Mar 26. Review.

PMID:
23528962
9.

Path to Personalized Medicine for Type 2 Diabetes Mellitus: Reality and Hope.

Aghaei Meybodi HR, Hasanzad M, Larijani B.

Acta Med Iran. 2017 Mar;55(3):166-174. Review.

10.

The role and impact of SNPs in pharmacogenomics and personalized medicine.

Laing RE, Hess P, Shen Y, Wang J, Hu SX.

Curr Drug Metab. 2011 Jun;12(5):460-86. Review.

PMID:
21453271
11.

Genomic Discoveries and Personalized Medicine in Neurological Diseases.

Zhang L, Hong H.

Pharmaceutics. 2015 Dec 7;7(4):542-53. doi: 10.3390/pharmaceutics7040542. Review.

12.

Personalized oncology: recent advances and future challenges.

Kalia M.

Metabolism. 2013 Jan;62 Suppl 1:S11-4. doi: 10.1016/j.metabol.2012.08.016. Epub 2012 Sep 19. Review.

PMID:
22999010
13.

Model-guided therapy for hepatocellular carcinoma: a role for information technology in predictive, preventive and personalized medicine.

Berliner L, Lemke HU, vanSonnenberg E, Ashamalla H, Mattes MD, Dosik D, Hazin H, Shah S, Mohanty S, Verma S, Esposito G, Bargellini I, Battaglia V, Caramella D, Bartolozzi C, Morrison P.

EPMA J. 2014 Sep 23;5(1):16. doi: 10.1186/1878-5085-5-16. eCollection 2014. Review.

14.

Overview of personalized medicine in the disease genomic era.

Hong KW, Oh B.

BMB Rep. 2010 Oct;43(10):643-8. doi: 10.5483/BMBRep.2010.43.10.643. Review.

15.

Policy perspectives on the emerging pathways of personalized medicine.

Downing GJ.

Dialogues Clin Neurosci. 2009;11(4):377-87. Review.

16.

Innovative payer engagement strategies: will the convergence lead to better value creation in personalized medicine?

Akhmetov I, Bubnov RV.

EPMA J. 2017 Feb 13;8(1):5-15. doi: 10.1007/s13167-017-0078-6. eCollection 2017 Dec. Review.

17.

The ethical framing of personalized medicine.

Joly Y, Saulnier KM, Osien G, Knoppers BM.

Curr Opin Allergy Clin Immunol. 2014 Oct;14(5):404-8. doi: 10.1097/ACI.0000000000000091. Review.

PMID:
25054830
18.

Genetics and genomics: the scientific drivers of personalized medicine.

Kurnat-Thoma EL.

Annu Rev Nurs Res. 2011;29:27-54. Review.

PMID:
22891497
19.

Personalized diagnostics and biosensors: a review of the biology and technology needed for personalized medicine.

Ahmed MU, Saaem I, Wu PC, Brown AS.

Crit Rev Biotechnol. 2014 Jun;34(2):180-96. doi: 10.3109/07388551.2013.778228. Epub 2013 Apr 22. Review.

PMID:
23607309
20.

Genetics, genomics, and cancer risk assessment: State of the Art and Future Directions in the Era of Personalized Medicine.

Weitzel JN, Blazer KR, MacDonald DJ, Culver JO, Offit K.

CA Cancer J Clin. 2011 Sep-Oct;61(5):327-59. doi: 10.3322/caac.20128. Epub 2011 Aug 19. Review.

Supplemental Content

Support Center